Dalton Greiner Hartman Maher & Co. Invests $74,000 in Digirad Co. (NASDAQ:DRAD)

Share on StockTwits

Dalton Greiner Hartman Maher & Co. purchased a new position in Digirad Co. (NASDAQ:DRAD) during the 3rd quarter, HoldingsChannel.com reports. The firm purchased 16,564 shares of the medical equipment provider’s stock, valued at approximately $74,000.

Separately, Weber Alan W purchased a new stake in shares of Digirad in the first quarter worth approximately $91,000. Hedge funds and other institutional investors own 38.18% of the company’s stock.

Separately, ValuEngine upgraded Digirad from a “hold” rating to a “buy” rating in a report on Thursday, October 3rd.

In other Digirad news, Director Jeffrey E. Eberwein purchased 300,000 shares of Digirad stock in a transaction dated Tuesday, September 10th. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $3,000,000.00. Following the completion of the acquisition, the director now owns 4,419 shares in the company, valued at approximately $44,190. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 7.30% of the company’s stock.

Shares of NASDAQ DRAD opened at $4.04 on Friday. The company has a current ratio of 1.42, a quick ratio of 1.03 and a debt-to-equity ratio of 0.77. The business’s 50 day moving average price is $4.63 and its 200-day moving average price is $3.70. Digirad Co. has a fifty-two week low of $3.97 and a fifty-two week high of $14.60.

Digirad (NASDAQ:DRAD) last issued its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.04 earnings per share for the quarter. Digirad had a negative return on equity of 10.97% and a negative net margin of 5.81%. The firm had revenue of $25.80 million for the quarter.

Digirad Profile

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.

See Also: What are economic reports?

Want to see what other hedge funds are holding DRAD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Digirad Co. (NASDAQ:DRAD).

Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.